REVANCE THERAPEUTICS

Serial Number 90862492
Registration 7811732
700

Registration Progress

Application Filed
Aug 3, 2021
Under Examination
Feb 15, 2022
Approved for Publication
Dec 21, 2021
Published for Opposition
Dec 21, 2021
Registered
May 27, 2025

Trademark Image

REVANCE THERAPEUTICS

Basic Information

Serial Number
90862492
Registration Number
7811732
Filing Date
August 3, 2021
Registration Date
May 27, 2025
Published for Opposition
December 21, 2021
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
May 27, 2025
Registration
Registered
Classes
005

Rights Holder

Revance Therapeutics, Inc.

03
Address
UNIT 8, THE OLIVIA CENTRE
373-375 ANTRIM ROAD
GLENGORMLEY BT365EB
GB

Ownership History

Revance Therapeutics, Inc.

Original Applicant
03
Nashville, TN

Revance Therapeutics, Inc.

Owner at Publication
03
Nashville, TN

Revance Therapeutics, Inc.

Original Registrant
03
GLENGORMLEY GB

Legal Representation

Attorney
Jennifer Waitman

USPTO Deadlines

Next Deadline
1943 days remaining
Section 8 Declaration Due (Principal Register)
Due Date
May 27, 2031
Grace Period Ends
November 27, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

48 events
Date Code Type Description Documents
Jan 20, 2026 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jan 20, 2026 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jan 20, 2026 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Aug 4, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Aug 4, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Aug 4, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Aug 4, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Aug 4, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
May 27, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
May 27, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
May 5, 2025 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
May 5, 2025 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Apr 30, 2025 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Feb 14, 2025 IUAF S USE AMENDMENT FILED Loading...
Apr 30, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Feb 14, 2025 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Aug 13, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 13, 2024 EX5G S SOU EXTENSION 5 GRANTED Loading...
Aug 13, 2024 EXT5 S SOU EXTENSION 5 FILED Loading...
Aug 13, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 15, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 14, 2024 EX4G S SOU EXTENSION 4 GRANTED Loading...
Feb 14, 2024 EXT4 S SOU EXTENSION 4 FILED Loading...
Feb 14, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 16, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 14, 2023 EX3G S SOU EXTENSION 3 GRANTED Loading...
Aug 14, 2023 EXT3 S SOU EXTENSION 3 FILED Loading...
Aug 14, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 16, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 14, 2023 EX2G S SOU EXTENSION 2 GRANTED Loading...
Feb 14, 2023 EXT2 S SOU EXTENSION 2 FILED Loading...
Feb 14, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 5, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 3, 2022 EX1G S SOU EXTENSION 1 GRANTED Loading...
Aug 3, 2022 EXT1 S SOU EXTENSION 1 FILED Loading...
Aug 3, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 15, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Dec 21, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 21, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 1, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 16, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 16, 2021 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Nov 16, 2021 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Nov 16, 2021 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Nov 16, 2021 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Nov 15, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 28, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 6, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, muscle spasms, and pain; pharmaceutical preparations, namely, peptide substrates for use in the treatment of neurological disorders, muscle dystonias, muscle spasms, and pain
First Use Anywhere: Aug 14, 2023
First Use in Commerce: Aug 14, 2023

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"